Skip to main content
Premium Trial:

Request an Annual Quote

Case Medical Center to Offer Exact's DNA Screening Test for Colon Cancer

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Exact Sciences said Monday that University Hospitals Case Medical Center of Cleveland has launched a program for stool-based DNA screening at two sites within its system.
 
Marlborough, Mass.-based Exact Sciences makes a stool-based DNA test for colorectal cancer screening, which is offered by licensing partner Laboratory Corporation of America. Earlier this year, its screening technology was included in the American Cancer Society’s updated guidelines for colorectal cancer screening.
 
According to the firm, its stool-based DNA test will be the preferred method for screening patients who are unwilling or unable to obtain a colonoscopy. Exact’s test screens for the Vimentin gene, which was discovered by a researcher at Case Western Reserve University.
 
The center intends to evaluate the program's performance to determine whether it will roll out the DNA screening program system-wide.
 
Case Medical Center’s decision to offer the stool-based DNA screening test follows an announcement last week by the Massachusetts Department of Public Health that it had added the test as an option for its Massachusetts Care Coordination Program for low-income men and women over age 40.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.